Literature DB >> 22518032

Electrical coupling and propagation in engineered ventricular myocardium with heterogeneous expression of connexin43.

Philippe Beauchamp1, Thomas Desplantez, Megan L McCain, Weihui Li, Angeliki Asimaki, Ghislaine Rigoli, Kevin Kit Parker, Jeffrey E Saffitz, Andre G Kleber.   

Abstract

RATIONALE: Spatial heterogeneity in connexin (Cx) expression has been implicated in arrhythmogenesis.
OBJECTIVE: This study was performed to quantify the relation between the degree of heterogeneity in Cx43 expression and disturbances in electric propagation. METHODS AND
RESULTS: Cell pairs and strands composed of mixtures of Cx43(-/-) (Cx43KO) or GFP-expressing Cx43(+/+) (WT(GFP)) murine ventricular myocytes were patterned using microlithographic techniques. At the interface between pairs of WT(GFP) and Cx43KO cells, dual-voltage clamp showed a marked decrease in electric coupling (approximately 5% of WT) and voltage gating suggested the presence of mixed Cx43/Cx45 channels. Cx43 and Cx45 immunofluorescence signals were not detectable at this interface, probably because of markedly reduced gap junction size. Macroscopic propagation velocity, measured by multisite high-resolution optical mapping of transmembrane potential in strands of cells of mixed Cx43 genotype, decreased with an increasing proportion of Cx43KO cells in the strand. A marked decrease in conduction velocity was observed in strands composed of <50% WT cells. Propagation at the microscopic scale showed a high degree of dissociation between WT(GFP) and Cx43KO cells, but consistent excitation without development of propagation block.
CONCLUSIONS: Heterogeneous ablation of Cx43 leads to a marked decrease in propagation velocity in tissue strands composed of <50% cells with WT Cx43 expression and marked dissociation of excitation at the cellular level. However, the small residual electric conductance between Cx43 and WT(GFP) myocytes assures excitation of Cx43(-/-) cells. This explains the previously reported undisturbed contractility in tissues with spatially heterogeneous downregulation of Cx43 expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22518032      PMCID: PMC3381798          DOI: 10.1161/CIRCRESAHA.111.259705

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

1.  Action potential propagation in inhomogeneous cardiac tissue: safety factor considerations and ionic mechanism.

Authors:  Y Wang; Y Rudy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

2.  Localization of sodium channels in intercalated disks modulates cardiac conduction.

Authors:  Jan P Kucera; Stephan Rohr; Yoram Rudy
Journal:  Circ Res       Date:  2002-12-13       Impact factor: 17.367

3.  Matrix-protein-specific regulation of Cx43 expression in cardiac myocytes subjected to mechanical load.

Authors:  Amit J Shanker; Kiyomi Yamada; Karen G Green; Kathryn A Yamada; Jeffrey E Saffitz
Journal:  Circ Res       Date:  2005-02-10       Impact factor: 17.367

4.  Control of myocyte remodeling in vitro with engineered substrates.

Authors:  Nicholas A Geisse; Sean P Sheehy; Kevin Kit Parker
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-02-28       Impact factor: 2.416

5.  Effects of diminished expression of connexin43 on gap junction number and size in ventricular myocardium.

Authors:  J E Saffitz; K G Green; W J Kraft; K B Schechtman; K A Yamada
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

6.  Properties of mouse connexin 30.2 and human connexin 31.9 hemichannels: implications for atrioventricular conduction in the heart.

Authors:  Feliksas F Bukauskas; Maria M Kreuzberg; Mindaugas Rackauskas; Angele Bukauskiene; Michael V L Bennett; Vytas K Verselis; Klaus Willecke
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-13       Impact factor: 11.205

7.  Reduced heterogeneous expression of Cx43 results in decreased Nav1.5 expression and reduced sodium current that accounts for arrhythmia vulnerability in conditional Cx43 knockout mice.

Authors:  John A Jansen; Maartje Noorman; Hassan Musa; Mèra Stein; Sanne de Jong; Roel van der Nagel; Thomas J Hund; Peter J Mohler; Marc A Vos; Toon A van Veen; Jacques M de Bakker; Mario Delmar; Harold V van Rijen
Journal:  Heart Rhythm       Date:  2011-11-16       Impact factor: 6.343

8.  Distinct pathways regulate expression of cardiac electrical and mechanical junction proteins in response to stretch.

Authors:  Kiyomi Yamada; Karen G Green; Allen M Samarel; Jeffrey E Saffitz
Journal:  Circ Res       Date:  2005-07-21       Impact factor: 17.367

9.  Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts.

Authors:  Stephan B Danik; Gregg Rosner; Joshua Lader; David E Gutstein; Glenn I Fishman; Gregory E Morley
Journal:  FASEB J       Date:  2007-11-05       Impact factor: 5.191

Review 10.  Basic mechanisms of cardiac impulse propagation and associated arrhythmias.

Authors:  André G Kléber; Yoram Rudy
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

View more
  18 in total

Review 1.  Electrical and mechanical stimulation of cardiac cells and tissue constructs.

Authors:  Whitney L Stoppel; David L Kaplan; Lauren D Black
Journal:  Adv Drug Deliv Rev       Date:  2015-07-30       Impact factor: 15.470

2.  Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids.

Authors:  Yu Tan; Dylan Richards; Robert C Coyle; Jenny Yao; Ruoyu Xu; Wenyu Gou; Hongjun Wang; Donald R Menick; Bozhi Tian; Ying Mei
Journal:  Acta Biomater       Date:  2017-01-10       Impact factor: 8.947

3.  Selective Cre-mediated gene deletion identifies connexin 43 as the main connexin channel supporting olfactory ensheathing cell networks.

Authors:  Ana Paula Piantanida; Luis Ernesto Acosta; Lucila Brocardo; Claudia Capurro; Charles A Greer; Lorena Rela
Journal:  J Comp Neurol       Date:  2019-01-21       Impact factor: 3.215

4.  Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells.

Authors:  Yu Tan; Dylan Richards; Ruoyu Xu; Skylar Stewart-Clark; Santhosh Kumar Mani; Thomas Keith Borg; Donald R Menick; Bozhi Tian; Ying Mei
Journal:  Nano Lett       Date:  2015-04-07       Impact factor: 11.189

5.  Novel Methods for High-resolution Assessment of Cardiac Action Potential Repolarization.

Authors:  Marianna Meo; Olivier Meste; Sergio Signore; Marcello Rota
Journal:  Biomed Signal Process Control       Date:  2019-02-18       Impact factor: 3.880

6.  GJA1-20k Arranges Actin to Guide Cx43 Delivery to Cardiac Intercalated Discs.

Authors:  Wassim A Basheer; Shaohua Xiao; Irina Epifantseva; Ying Fu; Andre G Kleber; TingTing Hong; Robin M Shaw
Journal:  Circ Res       Date:  2017-09-18       Impact factor: 17.367

7.  Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy.

Authors:  Stephen P Chelko; Angeliki Asimaki; Peter Andersen; Djahida Bedja; Nuria Amat-Alarcon; Deeptankar DeMazumder; Ravirasmi Jasti; Calum A MacRae; Remo Leber; Andre G Kleber; Jeffrey E Saffitz; Daniel P Judge
Journal:  JCI Insight       Date:  2016-04-21

8.  Protein Kinase C-Mediated Hyperphosphorylation and Lateralization of Connexin 43 Are Involved in Autoimmune Myocarditis-Induced Prolongation of QRS Complex.

Authors:  Chunlian Zhong; Huan Zhao; Xinwen Xie; Zhi Qi; Yumei Li; Lee Jia; Jinwei Zhang; Yusheng Lu
Journal:  Front Physiol       Date:  2022-03-28       Impact factor: 4.566

9.  Micropattern width dependent sarcomere development in human ESC-derived cardiomyocytes.

Authors:  Max R Salick; Brett N Napiwocki; Jin Sha; Gavin T Knight; Shahzad A Chindhy; Timothy J Kamp; Randolph S Ashton; Wendy C Crone
Journal:  Biomaterials       Date:  2014-02-28       Impact factor: 12.479

10.  Both PKA and Epac pathways mediate N-acetylcysteine-induced Connexin43 preservation in rats with myocardial infarction.

Authors:  Tsung-Ming Lee; Shinn-Zong Lin; Nen-Chung Chang
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.